| __timestamp | ADMA Biologics, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 79838000 |
| Thursday, January 1, 2015 | 7015946 | 121816000 |
| Friday, January 1, 2016 | 7688238 | 117633000 |
| Sunday, January 1, 2017 | 6229587 | 117456000 |
| Monday, January 1, 2018 | 3926120 | 171984000 |
| Tuesday, January 1, 2019 | 2343848 | 257452000 |
| Wednesday, January 1, 2020 | 5907013 | 477643000 |
| Friday, January 1, 2021 | 3646060 | 540684000 |
| Saturday, January 1, 2022 | 3613764 | 651496000 |
| Sunday, January 1, 2023 | 3300000 | 666563000 |
Cracking the code
In the ever-evolving world of biotechnology, research and development (R&D) are the lifeblood of innovation. Over the past decade, ADMA Biologics, Inc. and PTC Therapeutics, Inc. have demonstrated contrasting R&D investment strategies. ADMA Biologics, Inc. has seen a steady decline in R&D expenses, dropping from a peak in 2014 to a more modest investment in 2023. This represents a reduction of over 65% in their R&D spending. In contrast, PTC Therapeutics, Inc. has consistently ramped up its R&D efforts, with a staggering increase of over 730% from 2014 to 2023. This commitment to innovation is evident in their 2023 R&D expenses, which are nearly 20 times higher than those of ADMA Biologics, Inc. These trends highlight the diverse strategies within the biotech sector, where some companies prioritize aggressive R&D investment to drive future growth.
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs PTC Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
BioMarin Pharmaceutical Inc. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ADMA Biologics, Inc. Allocate Funds
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Research and Development Investment: Alkermes plc vs ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and ADMA Biologics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
R&D Insights: How PTC Therapeutics, Inc. and Xencor, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.